209 related articles for article (PubMed ID: 26202739)
1. Technological Evolution in the Development of Therapeutic Antibodies.
Fajardo-Ramírez ÓR; Ascacio-Martínez JA; Licea-Navarro AF; Villela-Martínez LM; Barrera-Saldaña HA
Rev Invest Clin; 2015; 67(3):158-69. PubMed ID: 26202739
[TBL] [Abstract][Full Text] [Related]
2. The use of antibodies in the treatment of infectious diseases.
Chan CE; Chan AH; Hanson BJ; Ooi EE
Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibodies for cancer immunotherapy: Current perspectives.
Müller D; Kontermann RE
BioDrugs; 2010 Apr; 24(2):89-98. PubMed ID: 20199124
[TBL] [Abstract][Full Text] [Related]
4. The Increasingly Human and Profitable Monoclonal Antibody Market.
Grilo AL; Mantalaris A
Trends Biotechnol; 2019 Jan; 37(1):9-16. PubMed ID: 29945725
[TBL] [Abstract][Full Text] [Related]
5. Bispecific antibodies for viral immunotherapy.
Nyakatura EK; Soare AY; Lai JR
Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody successes in the clinic.
Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
[TBL] [Abstract][Full Text] [Related]
7. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
8. Antibodies for therapeutic uses and the evolution of biotechniques.
Nieri P; Donadio E; Rossi S; Adinolfi B; Podestà A
Curr Med Chem; 2009; 16(6):753-79. PubMed ID: 19199935
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the generation of bispecific antibodies for tumor immunotherapy.
Kipriyanov SM; Le Gall F
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):233-42. PubMed ID: 15603258
[TBL] [Abstract][Full Text] [Related]
10. Bispecific antibodies in cancer immunotherapy.
Chen S; Li J; Li Q; Wang Z
Hum Vaccin Immunother; 2016 Oct; 12(10):2491-2500. PubMed ID: 27249163
[TBL] [Abstract][Full Text] [Related]
11. The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.
Niwa R; Satoh M
J Pharm Sci; 2015 Mar; 104(3):930-41. PubMed ID: 25583555
[TBL] [Abstract][Full Text] [Related]
12. Bispecific antibody conjugates in therapeutics.
Cao Y; Lam L
Adv Drug Deliv Rev; 2003 Feb; 55(2):171-97. PubMed ID: 12564976
[TBL] [Abstract][Full Text] [Related]
13. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic roles for antibody mixtures.
Raju TS; Strohl WR
Expert Opin Biol Ther; 2013 Oct; 13(10):1347-52. PubMed ID: 23886377
[TBL] [Abstract][Full Text] [Related]
15. Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.
Yang F; Wen W; Qin W
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036020
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of peritoneal carcinomatosis with catumaxomab.
Parsons SL
Onkologie; 2011; 34(3):86-7. PubMed ID: 21358211
[No Abstract] [Full Text] [Related]
17. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
Siberil S; Dutertre CA; Boix C; Teillaud JL
Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
[TBL] [Abstract][Full Text] [Related]
18. Bi-specific antibody therapy for the treatment of cancer.
Withoff S; Helfrich W; de Leij LF; Molema G
Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.
An Z
Protein Cell; 2010 Apr; 1(4):319-330. PubMed ID: 21203944
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Antibodies in Cancer Treatment in the UK.
Eltarhoni K; Kamel F; Ihebunezie K; Nisar P; Soloviev M
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
